Cas:149703-58-2 N-methyl-5-nitroquinoxalin-6-amine manufacturer & supplier

We serve Chemical Name:N-methyl-5-nitroquinoxalin-6-amine CAS:149703-58-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-methyl-5-nitroquinoxalin-6-amine

Chemical Name:N-methyl-5-nitroquinoxalin-6-amine
CAS.NO:149703-58-2
Synonyms:N-Methyl-5-nitro-6-quinoxalinamine;6-METHYLAMINO-5-NITROQUINOXALINE
Molecular Formula:C9H8N4O2
Molecular Weight:204.18500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:83.63000
Exact Mass:204.06500
LogP:2.17590

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-Methyl-5-nitro-6-quinoxalinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-METHYLAMINO-5-NITROQUINOXALINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Methyl-5-nitro-6-quinoxalinamine Use and application,N-Methyl-5-nitro-6-quinoxalinamine technical grade,usp/ep/jp grade.


Related News: Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. N-methyl-5-nitroquinoxalin-6-amine manufacturer Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China. N-methyl-5-nitroquinoxalin-6-amine supplier Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. N-methyl-5-nitroquinoxalin-6-amine vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. N-methyl-5-nitroquinoxalin-6-amine factory Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.